NFKBIL1
(Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor-Like 1 (NFKBIL1))
Protein Region
N-Term
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-NFKBIL1 antibody (Catalog #: ARP38540_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
NFKBIL1
(Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor-Like 1 (NFKBIL1))
Synonymes
Def-7 Peptide, IKBL Peptide, LST1 Peptide, NFKBIL Peptide, IkappaBL Peptide, nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor like 1 Peptide, NFKB inhibitor like 1 Peptide, Nfkbil1 Peptide, NFKBIL1 Peptide
Sujet
NFKBIL1 is a divergent member of the I-kappa-B family of proteins. Its function has not been determined. The gene lies within the major histocompatibility complex (MHC) class I region on chromosome 6. Multiple transcript variants encoding different isofor
Alias Symbols: IKBL, LST1, NFKBIL
Protein Interaction Partner: CXorf56,GEMIN4,KRT77,LUC7L,MRPL44,MRPS18B,MRPS22,MRPS34,PNN,RFXANK